|
MED20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19759999999791E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7776891070298E-12 |
| Normal-vs-Stage2 |
8.739400E-01 |
| Normal-vs-Stage3 |
9.936600E-01 |
| Normal-vs-Stage4 |
2.18440000532283E-08 |
| Stage1-vs-Stage2 |
2.730400E-01 |
| Stage1-vs-Stage3 |
2.250400E-01 |
| Stage1-vs-Stage4 |
3.923600E-01 |
| Stage2-vs-Stage3 |
8.934600E-01 |
| Stage2-vs-Stage4 |
2.061800E-01 |
| Stage3-vs-Stage4 |
1.533820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.166470E-04 |
| Normal-vs-AfricanAmerican |
1.917770E-01 |
| Normal-vs-Asian |
1.030560E-04 |
| Caucasian-vs-AfricanAmerican |
4.266200E-01 |
| Caucasian-vs-Asian |
3.799800E-01 |
| AfricanAmerican-vs-Asian |
1.922640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.194640E-04 |
| Normal-vs-Female |
2.863000E-03 |
| Male-vs-Female |
1.864850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.26779994783044E-09 |
| Normal-vs-Extreme_Weight |
2.437900E-03 |
| Normal-vs-Obese |
3.044400E-01 |
| Normal-vs-Extreme_Obese |
1.315580E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.016600E-01 |
| Normal_Weight-vs-Obese |
1.266630E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.992400E-01 |
| Extreme_Weight-vs-Obese |
2.524600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.305200E-01 |
| Obese-vs-Extreme_Obese |
5.491200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.824600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.160200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.275700E-02 |
| Normal-vs-Age(81-100Yrs) |
9.47609990475939E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.157800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.156800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.606400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.411400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.329790E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.467920E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.0101999993224E-08 |
| Normal-VS-Type2 PRCC |
4.773200E-01 |
| Normal-VS-KIRP CIMP |
6.738800E-01 |
| Normal-VS-Unclassified PRCC |
2.032500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.785400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.514800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.220800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.154800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.933200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.070800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.535370E-01 |
| Normal-vs-N1 |
7.177800E-01 |
| Normal-vs-N2 |
4.01809999994729E-06 |
| N0-vs-N1 |
2.641400E-01 |
| N0-vs-N2 |
2.065800E-01 |
| N1-vs-N2 |
5.978300E-02 |
|
|
